|
Volumn 20, Issue 1, 2004, Pages 39-40
|
TNF-α inhibition for potential therapeutic modulation of SARS coronavirus infection
|
Author keywords
Coronavirus; Etanercept; H5N1; SARS; TNF
|
Indexed keywords
ADALIMUMAB;
ETANERCEPT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL MODEL;
ARTICLE;
DISEASE SEVERITY;
DRUG SAFETY;
HUMAN;
IMMUNOGENICITY;
IMMUNOPATHOLOGY;
MOUSE;
NONHUMAN;
RESPIRATORY TRACT INFECTION;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
VIRUS INFECTION;
ANIMALS;
BIOLOGICAL RESPONSE MODIFIERS;
HUMANS;
IMMUNOGLOBULIN G;
RECEPTORS, TUMOR NECROSIS FACTOR;
SEVERE ACUTE RESPIRATORY SYNDROME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0347985434
PISSN: 03007995
EISSN: None
Source Type: Journal
DOI: 10.1185/030079903125002757 Document Type: Article |
Times cited : (50)
|
References (6)
|